Please use this identifier to cite or link to this item: https://doi.org/10.1158/0008-5472.CAN-07-1601
Title: Derivation of stable microarray cancer-differentiating signatures using consensus scoring of multiple random sampling and gene-ranking consistency evaluation
Authors: Zhi, Q.T.
Lian, Y.H.
Hong, H.L.
Cui, J.
Jia, J.
Boon, C.L. 
Bao, W.L. 
Yu, Z.C.
Issue Date: 15-Oct-2007
Citation: Zhi, Q.T., Lian, Y.H., Hong, H.L., Cui, J., Jia, J., Boon, C.L., Bao, W.L., Yu, Z.C. (2007-10-15). Derivation of stable microarray cancer-differentiating signatures using consensus scoring of multiple random sampling and gene-ranking consistency evaluation. Cancer Research 67 (20) : 9996-10003. ScholarBank@NUS Repository. https://doi.org/10.1158/0008-5472.CAN-07-1601
Abstract: Microarrays have been explored for deriving molecular signatures to determine disease outcomes, mechanisms, targets, and treatment strategies. Although exhibiting good predictive performance, some derived signatures are unstable due to noises arising from measurement variability and biological differences. Improvements in measurement, annotation, and signature selection methods have been proposed. We explored a new signature selection method that incorporates consensus scoring of multiple random sampling and multistep evaluation of gene-ranking consistency for maximally avoiding erroneous elimination of predictor genes. This method was tested by using a well-studied 62-sample colon cancer data set and two other cancer data sets (86-sample lung adenocarcinoma and 60-sample hepatocellular carcinoma). For the colon cancer data set, the derived signatures of 20 sampling sets, composed of 10,000 training test sets, are fairly stable with 80% of top 50 and 69% to 93% of all predictor genes shared by all 20 signatures. These shared predictor genes include 48 cancer-related and 16 cancer-implicated genes, as well as 50% of the previously derived predictor genes. The derived signatures outperform all previously derived signatures in predicting colon cancer outcomes from an independent data set collected from the Stanford Microarray Database. Our method showed similar performance for the other two data sets, suggesting its usefulness in deriving stable signatures for biomarker and target discovery. ©2007 American Association for Cancer Research.
Source Title: Cancer Research
URI: http://scholarbank.nus.edu.sg/handle/10635/96175
ISSN: 00085472
DOI: 10.1158/0008-5472.CAN-07-1601
Appears in Collections:Staff Publications

Show full item record
Files in This Item:
There are no files associated with this item.

SCOPUSTM   
Citations

15
checked on Dec 4, 2018

WEB OF SCIENCETM
Citations

17
checked on Nov 26, 2018

Page view(s)

50
checked on Dec 7, 2018

Google ScholarTM

Check

Altmetric


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.